Vitaly Vasilevko Selected Research

Therapeutics

1/2017	Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages.
7/2012	Mixed cerebrovascular disease and the future of stroke prevention.
10/2010	Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vitaly Vasilevko Research Topics

Disease

21	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 04/2003
6	Amyloid Plaque 05/2016 - 07/2006
5	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019 - 09/2008
5	Neuroinflammatory Diseases 01/2017 - 01/2010
4	Hemorrhage 01/2019 - 11/2011
4	Hypertension (High Blood Pressure) 02/2016 - 10/2010
4	Inflammation (Inflammations) 01/2016 - 07/2006
3	Down Syndrome (Down's Syndrome) 05/2017 - 12/2010
3	Gliosis 01/2014 - 12/2003
3	Cognitive Dysfunction 05/2013 - 01/2010
2	Cerebral Hemorrhage 01/2019 - 05/2013
2	Stroke (Strokes) 01/2019 - 07/2012
2	Dementia (Dementias) 05/2017 - 08/2012
2	Ischemic Stroke 01/2017 - 11/2011
2	Disease Progression 01/2017 - 04/2009
2	Meningoencephalitis 10/2006 - 02/2005
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019
1	Intellectual Disability (Idiocy) 05/2017
1	Sepsis (Septicemia) 01/2016
1	Brain Injuries (Brain Injury) 01/2016
1	Proteostasis Deficiencies 07/2014
1	Hemorrhagic Stroke 07/2012
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2012
1	Atherosclerosis 10/2010
1	Inclusion Body Myositis 05/2009
1	Autoimmune Diseases (Autoimmune Disease) 04/2003
1	Encephalomyelitis (Myeloencephalitis) 02/2003
1	Breast Neoplasms (Breast Cancer) 01/2003
1	Neoplasms (Cancer) 01/2003
1	Carcinoma (Carcinomatosis) 01/2003

Drug/Important Bio-Agent (IBA)

14	Amyloid beta-PeptidesIBA 01/2017 - 02/2003
12	Amyloid (Amyloid Fibrils)IBA 01/2016 - 02/2003
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2003
8	Peptides (Polypeptides)IBA 01/2014 - 12/2003
4	AntibodiesIBA 12/2007 - 12/2003
2	Erythropoietin FDA Link 01/2020 - 11/2018
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2020 - 11/2018
2	AnticoagulantsIBA 01/2019 - 07/2012
2	CytokinesIBA 11/2018 - 05/2013
2	ferric ferrocyanide (Prussian blue)FDA Link 01/2017 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2016
2	tau Proteins (tau Protein)IBA 08/2012 - 01/2010
2	AN-1792IBA 10/2006 - 02/2005
2	VaccinesIBA 02/2005 - 01/2003
1	Adenine FDA LinkGeneric 01/2020
1	Dabigatran FDA Link 01/2019
1	Neuroprotective AgentsIBA 11/2018
1	Glycoproteins (Glycoprotein)IBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	Biological ProductsIBA 01/2017
1	Fibrinogen (Factor I)FDA Link 01/2017
1	Claudin-5IBA 01/2017
1	Cilostazol (Pletal)FDA LinkGeneric 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Staphylococcal Protein A (Protein A)IBA 01/2017
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 05/2016
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2016
1	Angiotensin IIIBA 02/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016
1	HemosiderinIBA 01/2016
1	Hematoxylin (Haematoxylon)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Coloring Agents (Dyes)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 11/2014
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 01/2014
1	CopperIBA 01/2014
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014
1	CholesterolIBA 01/2014
1	ChemokinesIBA 05/2013
1	Bradykinin B1 ReceptorIBA 05/2013
1	CannabinoidsIBA 08/2012
1	anandamide (arachidonylethanolamide)IBA 08/2012
1	EndocannabinoidsIBA 08/2012
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 07/2012
1	Interleukin-1 (Interleukin 1)IBA 12/2011
1	CateninsIBA 12/2011
1	Dipyridamole (Persantine)FDA LinkGeneric 11/2011
1	Stearoyl-CoA DesaturaseIBA 01/2011
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2010
1	Minocycline (Cyclops)FDA LinkGeneric 01/2010
1	Immunoconjugates (Immunoconjugate)IBA 10/2006
1	MannansIBA 10/2006
1	Complement System Proteins (Complement)IBA 07/2006
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 02/2005
1	HLA-DR Antigens (HLA-DR)IBA 02/2005
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2005
1	DNA (Deoxyribonucleic Acid)IBA 12/2003
1	AntigensIBA 01/2003
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2003

Therapy/Procedure

6	Immunotherapy 10/2010 - 01/2003
3	Therapeutics 01/2017 - 10/2010
1	Nephrectomy 01/2020